POZEN INC Business Operations Contracts & Agreements
15 Contracts & Agreements
- Collaboration Agreements (7 contracts)
- Development Agreements (3)
- Services Agreements (2)
- Termination Agreements (2)
- Voting Agreements (1)
- Voting Agreement between POZEN Inc. and John R. Plachetka, dated May 29, 2015 (Filed With SEC on June 3, 2015)
- Termination Agreement, dated as of January 7, 2015, by and between POZEN Inc. and Cilag GmbH International (Cilag), a division of Johnson & Johnson (Filed With SEC on March 11, 2015)
- Termination Agreement, dated as of November 29, 2014, by and between POZEN Inc. and sanofi-aventis U.S. LLC (Filed With SEC on March 11, 2015)
- Second Amendment to Product Development and Commercialization Agreement dated as of July 30, 2014, by and between POZEN Inc. and Pernix Therapeutics Holdings, Inc (Filed With SEC on November 6, 2014)
- First Amendment to Product Development and Commercialization Agreement, dated as of May 13, 2014, by and between POZEN Inc. and Pernix Therapeutics Holdings, Inc (Filed With SEC on November 6, 2014)
- Amended and Restated Collaboration and License Agreement for outside of the United States by and between POZEN Inc. and AstraZeneca AB dated as of November 18, 2013 (Filed With SEC on March 6, 2014)
- Amended and Restated Collaboration and License Agreement for the United States by and between POZEN Inc. and AstraZeneca AB dated as of November 18, 2013 (Filed With SEC on March 6, 2014)
- Amendment No. 1 to Amended and Restated Collaboration and License Agreement for the United States by and between POZEN Inc. and Horizon Pharma U.S.A. Inc. dated as of November 18,... (Filed With SEC on March 6, 2014)
- License and Collaboration Agreement between POZEN Inc. and sanofi-aventis U.S. LLC, dated as of September 3, 2013 (Filed With SEC on November 6, 2013)
- First Amendment No. 3 to the Collaboration and License Agreement between POZEN Inc. and AstraZeneca AB, dated as of September 16, 2013 (Filed With SEC on November 6, 2013)
- First Amendment to Manufacturing Services Agreement between Patheon Pharmaceuticals Inc., and POZEN Inc., dated as of July 10, 2013 (Filed With SEC on August 7, 2013)
- Manufacturing Services Agreement, dates as December 19, 2011, by and between POZEN Inc. and Patheon Pharmaceuticals, Inc (Filed With SEC on March 9, 2012)
- AMENDMENTNO. 2 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 4, 2008)
- Amendment No. 1 to the Collaboration and License Agreement, dated September 6, 2007, between the Registrant and AstraZeneca, AB (Filed With SEC on November 5, 2007)
- PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on August 12, 2003)
